3-(pentadec-10-enyl)catechol
isolated from Lithraea caustica (Anacardiaceae); structure given in first source
Networked: 2
relevant articles (1 outcomes,
1 trials/studies)
Relationship Network
Bio-Agent Context: Research Results
Experts
Related Diseases
| 1. | Neoplasms (Cancer)
05/15/2009
- " Taken together, these results demonstrate that litreol attenuate the growth of human cancer cells, at least in part, triggering an apoptotic process, and they may offer a further impulse to the development of its analogues with more potent efficacy against human cancer cells." 05/15/2009
- " The results showed, for the first time, that litreol inhibited cancer cell viability in a dose-dependent manner. " 05/15/2009
- " Effect of litreol on the viability of human cancer cells." 05/15/2009
- " In the present study, human cancer cell lines, DU-145 cells (androgen-insensitive prostate cancer cells), KB cells (human epidermoid cells), and human melanoma cell line, M14, were treated for 72 h with 0.59-9.5 microM litreol (3-[pentadecyl-10-enyl-catechol]), a alkyl-catechol isolated from Lithraea caustica (Molina) Hook. "
|
| 2. | Prostatic Neoplasms (Prostate Cancer)
|
| 3. | Melanoma (Melanoma, Malignant)
|
| 4. | Contact Dermatitis (Eczema, Contact)
|
|
Related Drugs and Biologics